Clinical Trials Browser

Phase 1/2 × Withdrawn × Colorectal Cancer Metastatic × Clear all

NCT04031872 2025-09-05

LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)

Phase 1/2 Withdrawn

Gastrointestinal

Colorectal Cancer Metastatic

NCT04751955 2023-10-31

A Phase lb/ll, Open Label, Single Arm Study With Olinvacimab and Capecitabine in mCRC Patients (OLCAP)

Phase 1/2 Withdrawn

Gastrointestinal

Colorectal Cancer Metastatic

NCT03470350 2019-07-24

EORTC1615

Phase 1/2 Withdrawn

Gastrointestinal

Colorectal Cancer Metastatic